APH-1

Overview

APH-1 is a component of the gamma-secretase complex, which is an intramembrane protease complex involved in the cleavage of several type I transmembrane proteins. The gamma-secretase complex plays a crucial role in the Notch signaling pathway and the processing of amyloid precursor protein (APP), which is implicated in Alzheimer's disease.

Structure

The APH-1 protein is a multi-pass transmembrane protein that is part of the gamma-secretase complex. It is believed to stabilize the complex and facilitate its assembly. APH-1 contains several transmembrane domains and is encoded by the APH1A and APH1B genes in humans.

Function

APH-1 is essential for the proper assembly and function of the gamma-secretase complex. It interacts with other components of the complex, including presenilin, nicastrin, and PEN-2. The gamma-secretase complex is responsible for the proteolytic cleavage of several substrates, including Notch receptors and APP.

Role in Notch Signaling

In the Notch signaling pathway, gamma-secretase cleaves the Notch receptor, releasing the Notch intracellular domain (NICD), which translocates to the nucleus to regulate gene expression. APH-1 is crucial for the stability and activity of the gamma-secretase complex in this pathway.

Role in Alzheimer's Disease

Gamma-secretase is involved in the cleavage of APP, leading to the production of amyloid-beta peptides. Accumulation of amyloid-beta is a hallmark of Alzheimer's disease. APH-1, as part of the gamma-secretase complex, is indirectly involved in this process, making it a target of interest in Alzheimer's research.

Genetic Variants

There are two main human genes encoding APH-1 proteins: APH1A and APH1B. These genes give rise to different isoforms of the APH-1 protein, which may have distinct roles in the gamma-secretase complex.

Research and Implications

Research into APH-1 and its role in the gamma-secretase complex is ongoing, with implications for understanding and potentially treating conditions such as Alzheimer's disease and cancers involving aberrant Notch signaling.

- Weight loss injections in NYC (generic and brand names):
- Zepbound / Mounjaro, Wegovy / Ozempic, Saxenda
Most insurances accepted or discounted self-pay rates. We will obtain insurance prior authorizations if needed.
- Generic GLP1 weight loss injections from $125 for the starting dose.
Also offer prescription weight loss medications including Phentermine, Qsymia, Diethylpropion, Contrave etc.

NYC weight loss doctor appointments

Start your NYC weight loss journey today at our NYC medical weight loss and Philadelphia medical weight loss clinics.

Call 718-946-5500 to lose weight in NYC or for medical weight loss in Philadelphia 215-676-2334.
Tags:NYC medical weight loss, Philadelphia lose weight Zepbound NYC, Budget GLP1 weight loss injections, Wegovy Philadelphia, Wegovy NYC, Philadelphia medical weight loss, Brookly weight loss and Wegovy NYC

Advertise on WikiMD

WikiMD's Wellness Encyclopedia

Let Food Be Thy Medicine
Medicine Thy Food - Hippocrates

Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.